Position in GILD
as of Mar 31, 2026
· filed Jun 3, 2026
Position Value
$54,693,665
+$34,966,893 QoQ
Shares Held
392,435
+144.2% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NewEdge Advisors, LLC holds $721,115,080 across 17 Drug Manufacturers - General names. GILD ranks #4 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
888,033 | $217,070,786 | |
| 2 | LLY |
ELI LILLY & Co
|
184,095 | $169,325,058 | |
| 3 | ABBV |
AbbVie Inc.
|
632,140 | $137,484,128 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
392,435 | $54,693,665 | |
| 5 | MRK |
Merck & Co., Inc.
|
341,876 | $41,124,264 | |
| 6 | AMGN |
Amgen Inc
|
95,939 | $33,756,137 | |
| 7 | PFE |
Pfizer Inc
|
712,319 | $20,001,917 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
226,056 | $13,710,296 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $54,693,665 | 392,435 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $19,726,772 | 160,720 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $17,658,213 | 159,083 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $11,806,435 | 106,489 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,598,361 | 94,586 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,465,987 | 91,653 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,694,704 | 55,996 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,781,645 | 55,118 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $4,426,131 | 60,425 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,979,117 | 61,463 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,438,546 | 59,228 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,853,637 | 62,977 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,976,586 | 47,928 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,208,557 | 37,374 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,839,719 | 29,822 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,704,410 | 27,575 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,520,433 | 25,575 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,260,131 | 31,127 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $950,728 | 13,611 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $1,240,030 | 18,008 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $1,254,726 | 19,414 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,718,145 | 29,491 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $1,945,430 | 30,787 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $2,088,536 | 27,145 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $2,321,597 | 31,054 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||